(80) conducted a study involving 29 untreated patients with PD-L1-positive NSCLC who received a combination of low-dose radiation (2 Gy per fraction), SBRT (30 Gy in 3 fractions), and sintilimab. Here, CD274 is linked to non-small cell lung carcinoma.